South Korea Base Editing Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Platform and gRNA Design), By Application (Drug Discovery & Development, Agriculture and Veterinary), and South Korea Base Editing Market Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI13729
PAGES 170
REPORT FORMAT PathSoft

South Korea Base Editing Market Insights Forecasts to 2035

  • The South Korea Base Editing Market Size Was Estimated at USD 4.87 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 14.6% from 2025 to 2035
  • The South Korea Base Editing Market Size is Expected to Reach USD 21.8 Million by 2035

South Korea Base Editing Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The South Korea Base Editing Market Size is anticipated to reach USD 21.8 Million by 2035, growing at a CAGR of 14.6% from 2025 to 2035. The market is being driven by reasons such as the growing prevalence of uncommon and chronic diseases, the growing use of genomic research in therapies, the increased government financing, and the growing emphasis on genomic studies.

 

Market Overview

The base editing market involves advanced gene-editing technologies that enable precise DNA modifications by converting one base pair into another without causing double-strand breaks. This innovation allows scientists to correct point mutations responsible for many genetic diseases, offering safer and more efficient therapeutic alternatives to traditional CRISPR Cas9. Benefits include higher precision, reduced off target effects, and broader application in treating inherited disorders and cancers. Opportunities lie in expanding clinical trials, partnerships with pharmaceutical firms, and leveraging AI for target selection. Governments, including South Korea are increasingly supporting gene editing research through grants, biotech incubators, and regulatory streamlining. These initiatives are fostering innovation and commercialization, driving growth in this transformative segment of genomic medicine.

 

Report Coverage

This research report categorizes the market for South Korea base editing market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea base editing market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub segment South Korea base editing market.

 

South Korea Base Editing Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 4.87 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :14.6%
2035 Value Projection:USD 21.8 Million
Historical Data for:2020-2023
No. of Pages:170
Tables, Charts & Figures:110
Segments covered:By Product & Services and By Application
Companies covered:: GenKOre, ToolGen, Samsung Biologics, Helixmith, SillaJen, Lotte Biologics, MxT Biotech, Celltrion, Genexine, GC Genome, Bioneer, and Others
Pitfalls & Challenges:COVID-19 Impact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The rising prevalence of genetic disorders and the strong need for precise, targeted therapeutic interventions. Governments and private entities are increasing funding for genomic research, accelerating platform development, and regulatory support. The pharmaceutical and biotech companies are adopting base editing in pursuit of personalized medicine, benefiting from improved precision, reduced off target effects, and stable DNA level edits.

 

Restraining Factors

The ethical concerns and regulatory hurdles surrounding genome manipulation especially germline edits pose significant adoption challenges. The Off target effects and safety issues continue to raise alarms, slowing approvals. Technical limitations like delivery challenges, high R&D and manufacturing costs, and complex supply chain bottlenecks impede scalability.

 

Market Segmentation

The South Korea base editing market share is classified into product & services and application.

 

  • The platform segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea base editing market is segmented by product & services into platform and gRNA design. Among these, the platform segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. In genetic engineering, base editing platforms are instruments for precisely altering living things' DNA.  These platforms usually include a delivery method, guide RNA (gRNA), and a base editing enzyme.  To convert one base pair to another without generating double-strand breaks, the base editor enzyme is made to target particular nucleotides within the DNA sequence.

 

  • The drug discovery & development segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea base editing market is segmented by application into drug discovery & development, agriculture and veterinary. Among these, the drug discovery & development segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period.  Base editing technology can accurately alter single nucleotides in the genome without creating double strand breaks, it holds great promise for medication discovery and development. Its accuracy, base editing is a crucial technique for fixing genetic alterations linked to a number of illnesses, including those that are the focus of medication.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea base editing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • GenKOre
  • ToolGen
  • Samsung Biologics
  • Helixmith
  • SillaJen
  • Lotte Biologics
  • MxT Biotech
  • Celltrion
  • Genexine
  • GC Genome
  • Bioneer
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea base editing market based on the below-mentioned segments:

 

South Korea Base Editing Market, By Product & Services

  • Platform
  • gRNA Design

 

South Korea Base Editing Market, By Application

  • Drug Discovery & Development
  • Agriculture
  • Veterinary

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies